Page last updated: 2024-12-07

bis(2,3-dibromopropyl)phosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bis(2,3-dibromopropyl)phosphate: mutagenic,nephrotoxic metabolite of tris(2,3-dibromopropyl)phosphate, a flame retardant; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID91543
SCHEMBL ID481474
MeSH IDM0107981

Synonyms (28)

Synonym
1-propanol,3-dibromo-, hydrogen phosphate
bis(2,3-dibromopropyl)phosphate
bis(2,3-dibromopropyl)phosphoric acid
nsc3239
bis(2,3-dibromopropyl) hydrogen phosphate
nsc-3239
5412-25-9
brn 1712420
1-propanol, 2,3-dibromo-, hydrogen phosphate
einecs 226-493-4
ai3-19169
nsc 3239
1-propanol, 2,3-dibromo-, hydrogen phosphate (ester)
bis(2,3-dibromopropyl) phosphate
ccris 813
1-01-00-00182 (beilstein handbook reference)
1-propanol, 2,3-dibromo-, 1,1'-(hydrogen phosphate)
0fhm79990g ,
unii-0fhm79990g
FT-0635682
CBPKIOGAUWKEFT-UHFFFAOYSA-N
bis-(2,3-dibromopropyl) phosphoric acid
SCHEMBL481474
bis(2,3-dibromopropyl) phosphate, (+/-)-
DTXSID70275889
bis(2,3-dibromopropyl)phos-phate
Q27236713
bis(2,3-dibromopropyl) phoshate

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" LD50 values of male and female rats were 283 (253 approximately 314) mg/kg and 261 (219 approximately 310) mg/kg, respectively."( [Acute and subacute toxicity studies of Bis(2,3-dibromopropyl) phosphate magnesium in rat].
Aida, Y; Kurokawa, Y; Momma, J; Naito, K; Nakaji, Y; Takada, K; Tobe, M; Yoshimoto, H, 1991
)
0.28
" Aminooxyacetic acid, which prevents the formation of the ultimate toxic metabolite by inhibition of beta-lyase, abolished almost completely the toxicity of both compounds."( Isolated proximal tubular cells from rat kidney as an in vitro model for studies on nephrotoxicity. II. Alpha-methylglucose uptake as a sensitive parameter for mechanistic studies of acute toxicity by xenobiotics.
Boogaard, PJ; Mulder, GJ; Nagelkerke, JF, 1989
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (66.67)18.7374
1990's3 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 16.95

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index16.95 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.33 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (16.95)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]